Pharmaceutical Supply – METHOCARBAMOL TABLETS

The contract entails the supply of two bottles of FDA-approved methocarbamol tablets, adhering strictly to all federal pharmaceutical standards for quality, safety, and regulatory compliance. Each bottle must be properly labeled and packaged in accordance with federal guidelines, ensuring full traceability through the entire supply chain from manufacturer to end recipient. The item is being procured under a subcontract agreement issued by the Defense Logistics Agency, a component of the Department of Defense, and is categorized under NAICS code 325412 for pharmaceutical and biological product manufacturing. The contract was posted on July 14, 2026, and is linked to a specific award and delivery record within the DIBBS system, indicating its placement within the defense supply network. No set-aside provisions or specific geographic performance location are noted, suggesting the fulfillment is managed centrally under federal pharmaceutical procurement protocols.